FIGURE

Figure 7

ID
ZDB-FIG-220302-16
Publication
Copmans et al., 2022 - From the North Sea to Drug Repurposing, the Antiseizure Activity of Halimide and Plinabulin
Other Figures
All Figure Page
Back to All Figure Page
Figure 7

Behavioral antiseizure analysis of plinabulin after short- and long-term treatment in the zebrafish EKP seizure model. Antiseizure activity of plinabulin in the zebrafish ethyl ketopentenoate (EKP) seizure model after a treatment of 2 h (A,B) and after a treatment of 18 h (C,D). Behavioral data is expressed in mean actinteg units per 5 min intervals (±SEM) during the 10–25 min recording period (A,C) and over consecutive 5 min time intervals during the entire 30 min recording period (B,D). Data is normalized against the vehicle (VHC) + EKP control condition (B,D). Data were pooled from four independent experiments with 10 replicate wells per test condition (n = 40) (A,B) and from three or four independent experiments with 10 replicate wells per test condition (n = 70 for VHC + VHC and VHC + EKP, n = 28–30 for 5–10 µM plinabulin conditions, and n = 39–40 for 0.156–2.5 µM plinabulin conditions) (C,D). Statistical analysis: one-way ANOVA with Dunnett’s multiple comparison test (A,C), two-way ANOVA with Dunnett’s multiple comparison test (B,D) (GraphPad Prism 9, San Diego, CA, USA). Significance levels: * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001; **** p ≤ 0.0001.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Pharmaceuticals (Basel)